GlassScriptPhysician profile
Thomas A Bostaph
NPI 1093769127
$347.98
in general payments reported to CMS, 2019-2025
14 companies · $53.23 in 2025
The $53.23 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.30 · 2022: $95.21 · 2023: $79.71 · 2024: $106 · 2025: $53.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $56.11 | 2022-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $46.99 | 2021-2024 | Mounjaro |
| Novo Nordisk INC | $35.07 | 2023-2025 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $29.30 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $28.50 | 2022-2024 | |
| Phathom Pharmaceuticals, INC. | $20.97 | 2024 | Voquezna |
| Astellas Pharma US INC | $20.50 | 2023 | Veozah |
| Lundbeck LLC | $20.23 | 2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $18.88 | 2024 | |
| Abbvie INC. | $17.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.15 | 2024 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.81 | 2023 | Tradjenta, Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $13.20 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bostaph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.